X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare FDC LTD. with AJANTA PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FDC LTD. vs AJANTA PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FDC LTD. AJANTA PHARMA FDC LTD./
AJANTA PHARMA
 
P/E (TTM) x 19.6 18.9 103.6% View Chart
P/BV x 4.4 4.4 99.2% View Chart
Dividend Yield % 1.1 0.0 -  

Financials

 FDC LTD.   AJANTA PHARMA
EQUITY SHARE DATA
    FDC LTD.
Mar-14
AJANTA PHARMA
Mar-18
FDC LTD./
AJANTA PHARMA
5-Yr Chart
Click to enlarge
High Rs1441,818 7.9%   
Low Rs791,106 7.1%   
Sales per share (Unadj.) Rs47.6239.5 19.9%  
Earnings per share (Unadj.) Rs7.652.8 14.4%  
Cash flow per share (Unadj.) Rs9.059.5 15.1%  
Dividends per share (Unadj.) Rs2.250-  
Dividend yield (eoy) %2.00-  
Book value per share (Unadj.) Rs47.5230.0 20.7%  
Shares outstanding (eoy) m177.8388.77 200.3%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x2.36.1 38.3%   
Avg P/E ratio x14.627.7 52.8%  
P/CF ratio (eoy) x12.324.6 50.3%  
Price / Book Value ratio x2.36.4 36.8%  
Dividend payout %29.60-   
Avg Mkt Cap Rs m19,784129,782 15.2%   
No. of employees `000NA6.8 0.0%   
Total wages/salary Rs m1,2213,765 32.4%   
Avg. sales/employee Rs ThNM3,128.4-  
Avg. wages/employee Rs ThNM554.0-  
Avg. net profit/employee Rs ThNM689.7-  
INCOME DATA
Net Sales Rs m8,45921,258 39.8%  
Other income Rs m394242 162.9%   
Total revenues Rs m8,85221,499 41.2%   
Gross profit Rs m2,0706,584 31.4%  
Depreciation Rs m249596 41.8%   
Interest Rs m314 756.3%   
Profit before tax Rs m2,1846,226 35.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m-2250-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6061,539 39.3%   
Profit after tax Rs m1,3534,686 28.9%  
Gross profit margin %24.531.0 79.0%  
Effective tax rate %27.724.7 112.2%   
Net profit margin %16.022.0 72.6%  
BALANCE SHEET DATA
Current assets Rs m4,35512,236 35.6%   
Current liabilities Rs m1,7923,461 51.8%   
Net working cap to sales %30.341.3 73.4%  
Current ratio x2.43.5 68.7%  
Inventory Days Days4460 73.8%  
Debtors Days Days2584 29.2%  
Net fixed assets Rs m3,02511,140 27.2%   
Share capital Rs m179177 101.0%   
"Free" reserves Rs m8,24320,237 40.7%   
Net worth Rs m8,45320,414 41.4%   
Long term debt Rs m1110 105.9%   
Total assets Rs m10,55724,486 43.1%  
Interest coverage x71.41,519.4 4.7%   
Debt to equity ratio x00 255.8%  
Sales to assets ratio x0.80.9 92.3%   
Return on assets %13.119.2 68.4%  
Return on equity %16.023.0 69.7%  
Return on capital %23.530.5 77.1%  
Exports to sales %13.30-   
Imports to sales %3.30-   
Exports (fob) Rs m1,126NA-   
Imports (cif) Rs m283NA-   
Fx inflow Rs m1,14611,667 9.8%   
Fx outflow Rs m3551,616 22.0%   
Net fx Rs m79110,052 7.9%   
CASH FLOW
From Operations Rs m1,4852,854 52.0%  
From Investments Rs m-620-2,604 23.8%  
From Financial Activity Rs m-753-2 37,625.0%  
Net Cashflow Rs m113248 45.5%  

Share Holding

Indian Promoters % 68.9 73.8 93.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.7 1.6 303.2%  
FIIs % 7.5 7.6 98.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 19.0 17.0 111.8%  
Shareholders   23,730 20,968 113.2%  
Pledged promoter(s) holding % 0.0 4.4 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FDC LTD. With:   STRIDES SHASUN LTD  ELDER PHARMA  SUVEN LIFE  DR. DATSONS LABS  CADILA HEALTHCARE  

Compare FDC LTD. With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 132 Points Higher; IT and Healthcare Stocks Witness Buying(Closing)

After trading on a volatile note throughout the day, share markets in India witnessed buying interest during the closing hours and ended the day in green.

Related Views on News

FDC LTD. Announces Quarterly Results (1QFY19); Net Profit Up 74.5% (Quarterly Result Update)

Aug 6, 2018 | Updated on Aug 6, 2018

For the quarter ended June 2018, FDC LTD. has posted a net profit of Rs 511 m (up 74.5% YoY). Sales on the other hand came in at Rs 3 bn (up 16.7% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

AJANTA PHARMA Announces Quarterly Results (1QFY19); Net Profit Up 11.6% (Quarterly Result Update)

Aug 1, 2018 | Updated on Aug 1, 2018

For the quarter ended June 2018, AJANTA PHARMA has posted a net profit of Rs 1 bn (up 11.6% YoY). Sales on the other hand came in at Rs 5 bn (up 8.0% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

Don't Panic in This Falling Market... Do This Instead(The 5 Minute Wrapup)

Oct 5, 2018

Find companies with long term durable moats, which are correcting with the current broader market sell-off.

Why You Should Be Excited, Not Sad, About the 30% Small Cap Crash(Profit Hunter)

Oct 4, 2018

Smallcaps have corrected over 30% since the beginning of the year. Find out why Richa Agarwal views this as an opportunity rather than a threat.

Taxpayers to pay salaries of CEOs/CIOs of Mutual Funds(The Honest Truth)

Oct 5, 2018

Ajit Dayal on the crisis in the market and in the mutual fund industry.

Why Are Investors In Sundaram Small Cap Fund Anxious(Outside View)

Oct 3, 2018

A small cap fund that aims to capitalise on emerging businesses and catch them young. However, its failure in keeping volatility under check is making its investors anxious.

Biggest Corrections in the Stock of Infibeam Avenues(Chart Of The Day)

Oct 3, 2018

Infibeam plunged over 70% last week. This was the second biggest single-day fall. But Infibeam witnessed such sharp falls earlier.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

FDC LTD. SHARE PRICE


Oct 15, 2018 (Close)

TRACK FDC LTD.

  • Track your investment in FDC LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE FDC LTD. WITH

MARKET STATS